Commercialisation of Plant Based Medicines: Practical Case Studies
Wednesday 24 September
9.00 Greeting and opening speech (Dr.
9.20 Introduction to the programme (Prof.
09.30 – 12.30 Social and Economic Upliftment of Communities and their Countries through the protection of traditional knowledge (Chair: Dr.
09.30 Genetic resources and related traditional knowledge: a view from the negotiation room (Dr. Martin Girsberger, co-head, legal services Patents, Swiss Federal Institute of Intellectual Property)
10.15 Promotion of traditional knowledge for socio-economic benefit in
11.00 Coffee break
11.30 Socio-economic aspects of traditional knowledge: the role of the international community (Mr. Wend Wendland World Intellectual Property Organization (WIPO))
12.15 Discussion and comments
12.30 Lunch
13.45 – 15.30 Scientific validation of plant-based medicines
(Chair: Prof.
13.45 Development of products from bioprospecting leads: definition of a general strategy within CSIR Biosciences (Dr. Paolo Meoni, Council for Scientific and Industrial Research, SA)
14.15 Scientific validation of plant-based medicines in
14.45 Health promoting properties of Rooibos and Honeybush herbal tea (Prof. Wentzel Gelderblom, Medical Research Council, SA)
15.15 Discussion and comments
15.30 Coffee break
16.00 – 17.30 Regulation of plant-based medicines
(Chair: Dr.
16.00 Regulatory issues and the registration of plant-based medicines in
16.30 Practical case study (Dr. Christian Terraux, Vifor S.A.)
17.00 Regulatory issues and the registration of plant-based medicines in
17.15 Discussion and summing up of the day
Evening: Dinner (participants to be determined)
Thursday 25 September
09.00 – 10.45 Protection of intellectual property rights relating to IKS and plant-based medicines
(Chair: Prof.
9.00 Latest developments in
9.30 Amendments to IP and other legislation in
10.00 Latest developments in the discussions on the framework of the Convention on biological diversity (Mr.
10.30 Discussion and comments
10.45 Coffee break
11.15 – 13.00 Commercialization of plant-based medicines
(Chair: Dr.
11.15 Bioprospecting at the CSIR and the Hoodia case study (Dr. Vinesh Maharaj, Council for Scientific and Industrial Research, SA)
11.45 Development of Aloe ferox-based products – Baylabs case study (Prof.
12.15 The point of view of the Swiss industry (Mr. Hans Rietveld, Novartis)
12.45 Discussion and comments
13.00 Lunch
14.30 – 16.00 Inclusion of traditional/ plant-based medicines in mainstream public health systems
(Chair: Beatrice Stirner,
14.30 Education and training and the inclusion of traditional medicine in the public health system in SA (Prof. Nceba Gqaleni,
15.00 The situation in
15.30 The situation in
16.00 Coffee
16.30 Discussion and wrap-up
Evening: Dinner (participants to be determined)
Friday 26 September
Site visits to Weleda and Roche,
Departure from Geneva to Basel at 7 AM